Cancer Immunotherapy: CAR T as 'Car Race'

GEN Podcasts - En podkast av Genetic Engineering and Biotechnology News

Prøv Podimo gratis i hele 30 dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

Reklame

Kategorier:

Teknologi

GEN Sounds of Science March 9, 2017Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”? Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site